Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 434

Siegel segues to chairwoman role at The Engine

Former GE Ventures CEO Sue Siegel has been selected as chairwoman of the MIT-affiliated fund and accelerator The Engine.

Oct 5, 2020

Daily deal net: October 5, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Oct 5, 2020

Eclypsium secures $13m in series B round

AV8's Baris Aksoy has teamed up with his old unit Intel Capital in a round that lifted the cybersecurity software developer's overall funding to more than $24m.

Oct 5, 2020

Uber Freight ships in $500m

Uber's freight services subsidiary has secured series A funding from Greenbriar Equity Group in a deal valuing it at $3.3bn post-money.

Oct 5, 2020

C4 Therapeutics blows on to public markets

Dana-Farber Cancer Institute's cancer therapy developer raised $182m in an upsized IPO where it floated above its range.

Oct 5, 2020

Roblox to roll to IPO

Tencent-backed online gaming platform developer Roblox is in talks over an IPO or direct listing at a valuation of up to $8bn.

Oct 5, 2020

Siegel becomes chairwoman at The Engine

Sue Siegel, former CEO of GE Ventures, has been selected as chairwoman of the MIT-affiliated fund and accelerator.

Oct 5, 2020

Canadian Solar to cash $261m for spinoff

The cash will go to the solar energy provider's solar modules and systems subsidiary, CSI Solar, in advance of a planned IPO in China.

Oct 5, 2020

C4 Therapeutics blows on to public markets

The Roche, Novartis and Kraft Group-backed cancer therapy developer raised $182m in an upsized IPO where it floated above its range.

Oct 5, 2020

Carmot curates $47m series C round

Amgen has invested in Carmot Therapeutics having previously licensed a cancer drug candidate from the company that is currently in phase 2 clinical trials.

Oct 5, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here